CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 20, 2024

Primary Completion Date

October 20, 2027

Study Completion Date

October 20, 2027

Conditions
Aplastic Anemia
Interventions
DRUG

CD7 CAR-T cells injection

CD7 CAR T cells treat patients with severe aplastic anemia

OTHER

Allogeneic hematopoietic stem cell transplantation

In this study, Allogeneic hematopoietic stem cell transplantation is used as a bridge therapy to CD7 CAR T cells infusion to treat patients with severe aplastic anemia

Trial Locations (1)

310003

RECRUITING

The First Affiliated Hospital of Zhejiang University School of Medicine, Hanzhou

All Listed Sponsors
collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER